Cargando…

Phosphatidylinositol-4,5-Bisphosphate Binding to Amphiphysin-II Modulates T-Tubule Remodeling: Implications for Heart Failure

BIN1 (amphyphysin-II) is a structural protein involved in T-tubule (TT) formation and phosphatidylinositol-4,5-bisphosphate (PIP2) is responsible for localization of BIN1 to sarcolemma. The goal of this study was to determine if PIP2-mediated targeting of BIN1 to sarcolemma is compromised during the...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Junlan, Singh, Neha, Monnier, Chloe, Marszalec, William, Gao, Li, Jin, Jing, Frisk, Michael, Louch, William E., Verma, Suresh, Krishnamurthy, Prasanna, Nico, Elsa, Mulla, Maaz, Aistrup, Gary L., Kishore, Raj, Wasserstrom, J. Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733645/
https://www.ncbi.nlm.nih.gov/pubmed/35002765
http://dx.doi.org/10.3389/fphys.2021.782767
_version_ 1784627842794913792
author Zhou, Junlan
Singh, Neha
Monnier, Chloe
Marszalec, William
Gao, Li
Jin, Jing
Frisk, Michael
Louch, William E.
Verma, Suresh
Krishnamurthy, Prasanna
Nico, Elsa
Mulla, Maaz
Aistrup, Gary L.
Kishore, Raj
Wasserstrom, J. Andrew
author_facet Zhou, Junlan
Singh, Neha
Monnier, Chloe
Marszalec, William
Gao, Li
Jin, Jing
Frisk, Michael
Louch, William E.
Verma, Suresh
Krishnamurthy, Prasanna
Nico, Elsa
Mulla, Maaz
Aistrup, Gary L.
Kishore, Raj
Wasserstrom, J. Andrew
author_sort Zhou, Junlan
collection PubMed
description BIN1 (amphyphysin-II) is a structural protein involved in T-tubule (TT) formation and phosphatidylinositol-4,5-bisphosphate (PIP2) is responsible for localization of BIN1 to sarcolemma. The goal of this study was to determine if PIP2-mediated targeting of BIN1 to sarcolemma is compromised during the development of heart failure (HF) and is responsible for TT remodeling. Immunohistochemistry showed co-localization of BIN1, Cav1.2, PIP2, and phospholipase-Cβ1 (PLCβ1) in TTs in normal rat and human ventricular myocytes. PIP2 levels were reduced in spontaneously hypertensive rats during HF progression compared to age-matched controls. A PIP Strip assay of two native mouse cardiac-specific isoforms of BIN1 including the longest (cardiac BIN1 #4) and shortest (cardiac BIN1 #1) isoforms as well human skeletal BIN1 showed that all bound PIP2. In addition, overexpression of all three BIN1 isoforms caused tubule formation in HL-1 cells. A triple-lysine motif in a short loop segment between two helices was mutated and replaced by negative charges which abolished tubule formation, suggesting a possible location for PIP2 interaction aside from known consensus binding sites. Pharmacological PIP2 depletion in rat ventricular myocytes caused TT loss and was associated with changes in Ca(2+) release typically found in myocytes during HF, including a higher variability in release along the cell length and a slowing in rise time, time to peak, and decay time in treated myocytes. These results demonstrate that depletion of PIP2 can lead to TT disruption and suggest that PIP2 interaction with cardiac BIN1 is required for TT maintenance and function.
format Online
Article
Text
id pubmed-8733645
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-87336452022-01-07 Phosphatidylinositol-4,5-Bisphosphate Binding to Amphiphysin-II Modulates T-Tubule Remodeling: Implications for Heart Failure Zhou, Junlan Singh, Neha Monnier, Chloe Marszalec, William Gao, Li Jin, Jing Frisk, Michael Louch, William E. Verma, Suresh Krishnamurthy, Prasanna Nico, Elsa Mulla, Maaz Aistrup, Gary L. Kishore, Raj Wasserstrom, J. Andrew Front Physiol Physiology BIN1 (amphyphysin-II) is a structural protein involved in T-tubule (TT) formation and phosphatidylinositol-4,5-bisphosphate (PIP2) is responsible for localization of BIN1 to sarcolemma. The goal of this study was to determine if PIP2-mediated targeting of BIN1 to sarcolemma is compromised during the development of heart failure (HF) and is responsible for TT remodeling. Immunohistochemistry showed co-localization of BIN1, Cav1.2, PIP2, and phospholipase-Cβ1 (PLCβ1) in TTs in normal rat and human ventricular myocytes. PIP2 levels were reduced in spontaneously hypertensive rats during HF progression compared to age-matched controls. A PIP Strip assay of two native mouse cardiac-specific isoforms of BIN1 including the longest (cardiac BIN1 #4) and shortest (cardiac BIN1 #1) isoforms as well human skeletal BIN1 showed that all bound PIP2. In addition, overexpression of all three BIN1 isoforms caused tubule formation in HL-1 cells. A triple-lysine motif in a short loop segment between two helices was mutated and replaced by negative charges which abolished tubule formation, suggesting a possible location for PIP2 interaction aside from known consensus binding sites. Pharmacological PIP2 depletion in rat ventricular myocytes caused TT loss and was associated with changes in Ca(2+) release typically found in myocytes during HF, including a higher variability in release along the cell length and a slowing in rise time, time to peak, and decay time in treated myocytes. These results demonstrate that depletion of PIP2 can lead to TT disruption and suggest that PIP2 interaction with cardiac BIN1 is required for TT maintenance and function. Frontiers Media S.A. 2021-12-23 /pmc/articles/PMC8733645/ /pubmed/35002765 http://dx.doi.org/10.3389/fphys.2021.782767 Text en Copyright © 2021 Zhou, Singh, Monnier, Marszalec, Gao, Jin, Frisk, Louch, Verma, Krishnamurthy, Nico, Mulla, Aistrup, Kishore and Wasserstrom. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Physiology
Zhou, Junlan
Singh, Neha
Monnier, Chloe
Marszalec, William
Gao, Li
Jin, Jing
Frisk, Michael
Louch, William E.
Verma, Suresh
Krishnamurthy, Prasanna
Nico, Elsa
Mulla, Maaz
Aistrup, Gary L.
Kishore, Raj
Wasserstrom, J. Andrew
Phosphatidylinositol-4,5-Bisphosphate Binding to Amphiphysin-II Modulates T-Tubule Remodeling: Implications for Heart Failure
title Phosphatidylinositol-4,5-Bisphosphate Binding to Amphiphysin-II Modulates T-Tubule Remodeling: Implications for Heart Failure
title_full Phosphatidylinositol-4,5-Bisphosphate Binding to Amphiphysin-II Modulates T-Tubule Remodeling: Implications for Heart Failure
title_fullStr Phosphatidylinositol-4,5-Bisphosphate Binding to Amphiphysin-II Modulates T-Tubule Remodeling: Implications for Heart Failure
title_full_unstemmed Phosphatidylinositol-4,5-Bisphosphate Binding to Amphiphysin-II Modulates T-Tubule Remodeling: Implications for Heart Failure
title_short Phosphatidylinositol-4,5-Bisphosphate Binding to Amphiphysin-II Modulates T-Tubule Remodeling: Implications for Heart Failure
title_sort phosphatidylinositol-4,5-bisphosphate binding to amphiphysin-ii modulates t-tubule remodeling: implications for heart failure
topic Physiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733645/
https://www.ncbi.nlm.nih.gov/pubmed/35002765
http://dx.doi.org/10.3389/fphys.2021.782767
work_keys_str_mv AT zhoujunlan phosphatidylinositol45bisphosphatebindingtoamphiphysiniimodulatesttubuleremodelingimplicationsforheartfailure
AT singhneha phosphatidylinositol45bisphosphatebindingtoamphiphysiniimodulatesttubuleremodelingimplicationsforheartfailure
AT monnierchloe phosphatidylinositol45bisphosphatebindingtoamphiphysiniimodulatesttubuleremodelingimplicationsforheartfailure
AT marszalecwilliam phosphatidylinositol45bisphosphatebindingtoamphiphysiniimodulatesttubuleremodelingimplicationsforheartfailure
AT gaoli phosphatidylinositol45bisphosphatebindingtoamphiphysiniimodulatesttubuleremodelingimplicationsforheartfailure
AT jinjing phosphatidylinositol45bisphosphatebindingtoamphiphysiniimodulatesttubuleremodelingimplicationsforheartfailure
AT friskmichael phosphatidylinositol45bisphosphatebindingtoamphiphysiniimodulatesttubuleremodelingimplicationsforheartfailure
AT louchwilliame phosphatidylinositol45bisphosphatebindingtoamphiphysiniimodulatesttubuleremodelingimplicationsforheartfailure
AT vermasuresh phosphatidylinositol45bisphosphatebindingtoamphiphysiniimodulatesttubuleremodelingimplicationsforheartfailure
AT krishnamurthyprasanna phosphatidylinositol45bisphosphatebindingtoamphiphysiniimodulatesttubuleremodelingimplicationsforheartfailure
AT nicoelsa phosphatidylinositol45bisphosphatebindingtoamphiphysiniimodulatesttubuleremodelingimplicationsforheartfailure
AT mullamaaz phosphatidylinositol45bisphosphatebindingtoamphiphysiniimodulatesttubuleremodelingimplicationsforheartfailure
AT aistrupgaryl phosphatidylinositol45bisphosphatebindingtoamphiphysiniimodulatesttubuleremodelingimplicationsforheartfailure
AT kishoreraj phosphatidylinositol45bisphosphatebindingtoamphiphysiniimodulatesttubuleremodelingimplicationsforheartfailure
AT wasserstromjandrew phosphatidylinositol45bisphosphatebindingtoamphiphysiniimodulatesttubuleremodelingimplicationsforheartfailure